compounding altered- release pharmaceuticalsf...slide 2 compounding altered-release...
TRANSCRIPT
Slide 1
Compounding AlteredCompounding Altered--Release PharmaceuticalsRelease Pharmaceuticals
Part IVPart IV
Loyd V. Allen, Jr., Ph.D.Loyd V. Allen, Jr., Ph.D.
Slide 2
Compounding AlteredCompounding Altered--Release Release PharmaceuticalsPharmaceuticals--Part IVPart IV
ParenteralParenteralMiscellaneousMiscellaneousDrug Examples that are Good CandidatesDrug Examples that are Good CandidatesExcipientsExcipients Used For AlteredUsed For Altered--Release Release PharmaceuticalsPharmaceuticalsSummary/ConclusionsSummary/Conclusions
Slide 3
Compounding AlteredCompounding Altered--ReleaseReleasePharmaceuticalsPharmaceuticals--Part IVPart IV
ParenteralParenteral–– InternalInternal–– ExternalExternal–– IV DripIV Drip–– IM InjectionIM Injection
Slide 4
Compounding Compounding ParenteralsParenterals
Slide 5
InternalInternal
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 6
InternalInternal
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Slide 7
HydromorphoneHydromorphone 2% and 2% and BupivacaineBupivacaine HClHCl 0.75% 0.75% IntrathecalIntrathecal Injection, PFInjection, PF
HydromorphoneHydromorphone HClHCl USPUSP 2 g2 gBupivacaineBupivacaine HClHCl UspUsp 750 mg750 mg0.9% Sodium chloride 0.9% Sodium chloride injinj 42 mL42 mLSterile water for injection qsSterile water for injection qs 100 mL100 mL
Slide 8
Morphine sulfate 20 mg/mL and Morphine sulfate 20 mg/mL and ClonidineClonidine HClHCl 10 10 ug/mLug/mL
Epidural InjectionEpidural Injection
Morphine sulfateMorphine sulfate 2 g 2 g ClonidineClonidine HClHCl 1 mg1 mg0.9% Sodium chloride injection 0.9% Sodium chloride injection 69 mL69 mLSterile water for injectionSterile water for injection qsqs 100 mL100 mL
Slide 9
IV Drip/InfusionIV Drip/Infusion
Factors AffectingFactors Affecting–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 10
IV Drip/InfusionIV Drip/Infusion
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Slide 11
IM InjectionIM Injection
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 12
IM InjectionIM Injection
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Slide 13
Progesterone 100 mg/mL in Oil Progesterone 100 mg/mL in Oil InjectionInjection
ProgesteroneProgesterone 10 g10 gBenzyl benzoateBenzyl benzoate 10 mL10 mLBenzyl alcoholBenzyl alcohol 10 mL10 mLSesame oilSesame oil qsqs 100 mL100 mL
Slide 14
ExternalExternal
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 15
ExternalExternal
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Slide 16
Ambulatory PumpsAmbulatory Pumps
Slide 17
CeftazidimeCeftazidime 20 mg/mL for 20 mg/mL for Ambulatory Infusion PumpAmbulatory Infusion Pump
CeftazidimeCeftazidime 2.5 g2.5 gSterile water for injectionSterile water for injection qsqs0.9% Sodium chloride 0.9% Sodium chloride injinj qsqs 125 mL125 mL
Slide 18
Compounding AlteredCompounding Altered--Release Release PharmaceuticalsPharmaceuticals
MiscellaneousMiscellaneous–– Soaking a membrane or gelatin in solution Soaking a membrane or gelatin in solution
(casting)(casting)–– CyclodextrinsCyclodextrins–– ImplantsImplants–– NanoparticlesNanoparticles–– Resealed ErythrocytesResealed Erythrocytes–– Antibiotic Bone CementAntibiotic Bone Cement–– Antibiotic Beads ImplantedAntibiotic Beads Implanted–– SelfSelf--Regulated Chelating AgentsRegulated Chelating Agents
Slide 19
Soaking A Membrane or Gelatin Soaking A Membrane or Gelatin in Solution (Casting)in Solution (Casting)
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 20
Soaking A Membrane or Gelatin Soaking A Membrane or Gelatin in Solution (Casting)in Solution (Casting)
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Topical ApplicationTopical Application
Slide 21
CyclodextrinsCyclodextrins
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 22
CyclodextrinsCyclodextrins
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Slide 23
Slide 24
Slide 25
ImplantsImplants
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 26
ImplantsImplants
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/Matrices (Mg Stearate, PLA, PGA, Materials/Matrices (Mg Stearate, PLA, PGA, Silicone Polymers)Silicone Polymers)Preparation MethodsPreparation Methods
Slide 27
Fibrin GlueFibrin Glue
AprotininAprotinin 70,000 KIU70,000 KIUThrombinThrombin 10,000 IU10,000 IUCalcium chloride 0.5 M solCalcium chloride 0.5 M sol 2 mL2 mL
Slide 28
NanoparticlesNanoparticles
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 29
NanoparticlesNanoparticles
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Slide 30
Resealed ErythrocytesResealed Erythrocytes
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Slide 31
Resealed ErythrocytesResealed Erythrocytes
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods
Slide 32
Resealed ErythrocytesResealed Erythrocytes
Whole BloodWhole BloodSpin it down and remove the red blood cellsSpin it down and remove the red blood cellsPlace in sterile hypotonic saline or waterPlace in sterile hypotonic saline or waterAdd concentrated sterile solution of drugAdd concentrated sterile solution of drugReadjust tonicity to isotonicReadjust tonicity to isotonicErythrocytes will Erythrocytes will ““resealreseal””Administer to patientAdminister to patient………….last up to 3 weeks.last up to 3 weeks
Slide 33
Antibiotic Bone CementAntibiotic Bone Cement
Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility
Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/Matrices (Materials/Matrices (PalacosPalacos Bone Cement + Drug)Bone Cement + Drug)Preparation MethodsPreparation Methods
Slide 34
TobramycinTobramycin--Impregnated Impregnated PolymethylmethacrylatePolymethylmethacrylate BeadsBeads
TobramycinTobramycin sulfatesulfate 1.2 g1.2 gPalacosPalacos Bone CementBone Cement 40 g40 g
0.25 inch beads contain approx 3.26 mg of 0.25 inch beads contain approx 3.26 mg of tobramycintobramycin (as the sulfate)(as the sulfate)
Slide 35
VancomycinVancomycin 5 mg Sponge Disks5 mg Sponge Disks
VancomycinVancomycin HClHCl 5 mg5 mgSponge (collagen or gelatin)Sponge (collagen or gelatin) qsqs
Slide 36
Compounding AlteredCompounding Altered--Release Release PharmaceuticalsPharmaceuticals
Drug Examples That Are Good CandidatesDrug Examples That Are Good CandidatesThe lower the dose the betterThe lower the dose the betterLower solubility is betterLower solubility is betterShort halfShort half--life life vsvs long halflong half--lifelifeLarge therapeutic indexLarge therapeutic index
Slide 37
Drug Examples That Are Good Drug Examples That Are Good CandidatesCandidates
SolubilitySolubilityDoseDoseADMEADME----Duration of actionDuration of actionPharmacokineticsPharmacokinetics
Slide 38
Compounding AlteredCompounding Altered--Release Release PharmaceuticalsPharmaceuticals
Summary/ConclusionsSummary/ConclusionsYES, some are feasibleYES, some are feasibleNo, some are notNo, some are notQuality Control is importantQuality Control is importantAlways monitor clinical responseAlways monitor clinical response
Slide 39
A LOOK INTO THEA LOOK INTO THENEAR FUTURENEAR FUTURE
New Compounded Drug Delivery Systems New Compounded Drug Delivery Systems (DDS)(DDS)Next 5Next 5--10 years10 years
Slide 40
Future TrendsFuture Trends
Adhesive SiteAdhesive Site--Specific DDSSpecific DDSAntibodyAntibody--Based DDSBased DDSBiocompatible Biocompatible MicrosphereMicrosphere DDSDDSBiodegradable Polymers DDSBiodegradable Polymers DDSBiologicBiologic--Based DDSBased DDSElectromagnetic/RadiationElectromagnetic/Radiation--Activated DDSActivated DDS
Slide 41
Future TrendsFuture Trends
ImmunomodulatorImmunomodulator DDSDDSImplantImplant--Enhanced DDSEnhanced DDSMicroorganismMicroorganism--Containing MicrocapsulesContaining MicrocapsulesLipid Lipid MicrocylindersMicrocylindersLiposome EnhancementsLiposome EnhancementsLivingLiving--Cell TherapiesCell Therapies
Slide 42
Future TrendsFuture Trends
Magnetic System DDSMagnetic System DDSMazeMaze--Escape DDSEscape DDSMonoclonal Antibody DDSMonoclonal Antibody DDSNovel Nasal DDSNovel Nasal DDSNew Osmotic DDSNew Osmotic DDSTransmucosalTransmucosal DDSDDSPolymer Drug Complex DDSPolymer Drug Complex DDS
Slide 43
Future TrendsFuture Trends
PulsatilePulsatile DDSDDSRespiratory DDSRespiratory DDSSelfSelf--Assembling Controlled Release DDSAssembling Controlled Release DDSProgrammed Skin Surface DDSProgrammed Skin Surface DDS
Slide 44